Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Couture

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Chest|May 5, 2016
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening StudyAlain Tremblay, Niloofar Taghizadeh, Annette M McWilliams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Plos Genetics|December 5, 2012
Lung eQTLs to help reveal the molecular underpinnings of asthmaKe Hao, Yohan Bossé, David C Nickle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancerJean-Claude Cutz, Kenneth J Craddock, Emina Torlakovic, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Chest|May 5, 2016
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening StudyAlain Tremblay, Niloofar Taghizadeh, Annette M McWilliams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Plos Genetics|December 5, 2012
Lung eQTLs to help reveal the molecular underpinnings of asthmaKe Hao, Yohan Bossé, David C Nickle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancerJean-Claude Cutz, Kenneth J Craddock, Emina Torlakovic, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 13